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ABSTRACT Periprosthetic joint infection (PJI) is a potentially devastating complica-
tion of orthopedic joint replacement surgery. PJI with associated osteomyelitis is
particularly problematic and difﬁcult to cure. Whether viable osteocytes, the pre-
dominant cell type in mineralized bone tissue, have a role in these infections is not
clear, although their involvement might contribute to the difﬁculty in detecting and
clearing PJI. Here, using Staphylococcus aureus, the most common pathogen in PJI,
we demonstrate intracellular infection of human-osteocyte-like cells in vitro and
S. aureus adaptation by forming quasi-dormant small-colony variants (SCVs). Con-
sistent patterns of host gene expression were observed between in vitro-infected
osteocyte-like cultures, an ex vivo human bone infection model, and bone sam-
ples obtained from PJI patients. Finally, we conﬁrm S. aureus infection of osteo-
cytes in clinical cases of PJI. Our ﬁndings are consistent with osteocyte infection
being a feature of human PJI and suggest that this cell type may provide a res-
ervoir for silent or persistent infection. We suggest that elucidating the molecu-
lar/cellular mechanism(s) of osteocyte-bacterium interactions will contribute to
better understanding of PJI and osteomyelitis, improved pathogen detection, and
treatment.
IMPORTANCE Periprosthetic joint infections (PJIs) are increasing and are recognized
as one of the most common modes of failure of joint replacements. Osteomyelitis
arising from PJI is challenging to treat and difﬁcult to cure and increases patient
mortality 5-fold. Staphylococcus aureus is the most common pathogen causing PJI.
PJI can have subtle symptoms and lie dormant or go undiagnosed for many years,
suggesting persistent bacterial infection. Osteocytes, the major bone cell type, reside
in bony caves and tunnels, the lacuno-canalicular system. We report here that S. au-
reus can infect and reside in human osteocytes without causing cell death both ex-
perimentally and in bone samples from patients with PJI. We demonstrate that os-
teocytes respond to infection by the differential regulation of a large number of
genes. S. aureus adapts during intracellular infection of osteocytes by adopting the
quasi-dormant small-colony variant (SCV) lifestyle, which might contribute to persis-
tent or silent infection. Our ﬁndings shed new light on the etiology of PJI and osteo-
myelitis in general.
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Joint arthroplasty is a common and highly successful procedure; however, more than1% of primary hip (1) and 1 to 3% of primary knee (2) arthroplasties fail due to
periprosthetic joint infection (PJI). PJI carries a high risk of in-hospital and 5-year
mortality (3, 4), and the cure rate after 2 years has been reported to be as low as 67%
(5). These poor outcomes are due in part to incomplete knowledge of PJI disease
etiology (6). In bone, osteoblasts (7) and osteoclasts (8) have been investigated in
relation to bacterial infection. However, insufﬁcient attention has been given to the role
of the osteocyte in bone infection, despite this cell type constituting approximately
90 to 95% of cells in bone (9, 10). It has been reported that bacteria can reside in
osteocytes in vivo (11, 12), and a recent study (13) demonstrated the ability of
Staphylococcus aureus to invade the lacuno-canalicular spaces of cortical bone in an
experimental osteomyelitis model, although infection of osteocytes per se was not
reported in that study. The result of direct interaction between human osteocytes and
bacteria remains to be investigated.
Staphylococci, in particular S. aureus and the coagulase-negative species Staphylo-
coccus epidermidis, have been identiﬁed as the most common causative pathogens in
bone infection (14, 15). In this study, S. aureus was investigated because of its common
association with bone infection and its well-characterized ability to exist in the quasi-
dormant small-colony variant (SCV) lifestyle, which potentially contributes to a chronic
disease state (16). The interaction between human osteocytes and S. aureus was
investigated ﬁrst by experimental infection using the WCH-SK2 strain (17), a methicillin-
resistant S. aureus (MRSA) strain, at deﬁned multiplicities of infection (MOIs). We utilized
our well-characterized model of human-osteocyte-like cells generated by differentia-
tion of human primary osteoblastic cultures to a mature, osteocyte-like state (18, 19).
Day 28 differentiated osteocyte-like cells (Fig. S1) were cocultured with WCH-SK2 for
2 h, after which time extracellular bacteria were lysed using lysostaphin and washed to
remove debris, leaving only internalized bacteria. There was no effect of infection on
osteocyte-like cell viability, evidenced by the similar total cell numbers between the
control and infected groups 30 days postinfection (Fig. 1A). Using live-cell imaging,
uninfected osteocyte-like cells were observed to be relatively quiescent (see Movie S1
in the supplemental material), whereas cells exposed to green ﬂuorescent protein
(GFP)-expressing S. aureus (strain RN6390 [20]) were measurably active, with cell
membranes and dendritic processes moving on average 25 m nondirectionally in a
19-h time frame (Movie S2; Fig. 1B). Osteocyte-like cells were observed to have
internalized WCH-SK2 cells; by 24 h postinfection, both dying bacteria with compro-
mised cell walls (Fig. 1C) and actively proliferating S. aureus cells were observed in host
cells (Fig. 1D to F). Among the proliferating S. aureus cells, distinctive phenotypes of
dividing bacteria, including those with symmetrical and completely separated cell walls
(Fig. 1D) and those with asymmetrical and incompletely separated cell walls (Fig. 1E and
F), were observed. S. aureus cells with uneven and/or incomplete division were
previously characterized as an adaptation to stress and, possibly, the initiation of SCV
development. SCVs have a lower growth rate and lower virulence than normal cells but
are able to persist inside host cells (16), avoiding immune and therapeutic antimicrobial
interventions. Indeed, distinct bacterial colony types were grown from osteocyte-like
lysates of cells of large (1-mm) or small (0.2-mm) sizes, the latter appearing as
unpigmented (Fig. 1G). Overall, the total number of recovered CFU decreased from
~105 per well at day 1 to ~1,500 per well at day 5 (Fig. 1H). At day 5, approximately 80%
of the total recovered colonies were of the small, unpigmented phenotype (Fig. 1G and
H). A comparison of the gene expression proﬁles of the small and large colonies (in
pools of 10 colonies of each type) showed that the metabolism-related genes accessory
gene regulator A (agrA), staphylococcal accessory regulator A (sarA), and alkaline
shock protein 23 (asp23) and the bacterial-virulence-related genes alpha-hemolysin
(hla) and delta-hemolysin (hld) were not different between colony types, whereas the
stress adaptation-related gene sigma factor B (sigB) was found to be increased 50-fold
in small colonies (Fig. 1I). These data are consistent with those of previous studies
showing that the formation of SCV cell types is strongly associated with sigB expression
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FIG 1 In vitro interaction between primary human-osteocyte-like cells and S. aureus. (A) Viability of
osteocyte-like cells determined by DAPI staining of nuclei in the control (Ctrl) and infected (Inf) groups
30 days postinfection. (B) Time-lapse recording (13 to 18 h) of in vitro-differentiated human-osteocyte-like
cell movement under S. aureus (strain RN6390; GFP labeled) infection. The sum of plasma membrane
movements during the observation period was determined; data shown represent means standard errors
of the means (SEM) for a pool of 10 cells from each of the Ctrl and Inf groups (P  0.0001). TEM images
of infected osteocyte-like cells showing dying S. aureus cells with compromised cell walls (C), proliferating
S. aureus cells with evenly and completely divided cell walls (D), and proliferating S. aureus cells with
unevenly and incompletely divided cell walls (E and F). (G) Recovered intracellular S. aureus on days 1, 3,
and 5 featured with large and small (red arrowheads) sizes. (H) Quantiﬁcation of intracellular and
extracellular viable S. aureus CFU from days 1 to 5 (left y axis) and the percentage of small colonies
recovered from host cells (right y axis) (graphs represent results from 3 independent biological replicates;
values are means of results from the pool SEM). (I) Relative mRNA levels (normalized to 16S rRNA) of agrA,
sarA, asp23, hla, hld, and sigB in recovered small and large colonies (values represent means from 3
independent biological replicates  SEM). (J) Relative mRNA (normalized to 18S mRNA) levels of CCL5,
CXCL1, CXCL8, CXCL9, CXCL10, and CXCL11 at 24 h in osteocyte-like cells under control, killed-S. aureus
WCH-SK2 and live-S. aureus WCH-SK2 treatments with an MOI of 100. Data shown are means of normalized
expression  SEM from 4 independent biological replicates. Comparisons (t tests) and P values are
(Continued on next page)
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level (21, 22). Our ﬁnding suggests that the development of SCVs was initiated
following internalization by human-osteocyte-like cells. In response to S. aureus inva-
sion, the expression of a number of chemokine genes, including the neutrophil
chemoattractants CCL5, CXCL1, and CXCL8 and chemokines related to T cell activation,
CXCL9, CXCL10, and CXCL11, was strongly upregulated. The elevation of these chemo-
kines was dependent on exposure to live S. aureus and did not occur in the presence
of heat-killed cells (Fig. 1J). The protein production of CCL5 (regulated upon activation,
normal T cell expressed and secreted [RANTES]) and CXCL10 (interferon gamma-
induced protein 10 [IP10]) but not CXCL8 (interleukin-8 [IL-8]) were conﬁrmed to be
secreted by exposed osteocyte-like cells in an MOI-dependent manner (Fig. 1K). A
comprehensive transcription proﬁle of the osteocyte-like cell response to S. aureus
WCH-SK2 exposure in vitro was determined by microarray and bioinformatics analyses.
These revealed a large set of 1,526 differentially expressed genes (Fig. S2A). Network
analysis revealed numerous gene ontology (GO) term “communities” relating to a
variety of host innate immune responses and cell metabolic activities (Fig. S2B).
To investigate whether S. aureus is capable of penetrating human cancellous bone
to contact osteocytes, fresh bone specimens were tested for susceptibility to bacterial
infection ex vivo. Following a 12-h culture period, the presence of S. aureus in both
occupied (Fig. 2A and B) and empty (Fig. 2C) osteocyte lacunae was observed by
immunostaining. The speciﬁcity of antibody staining was validated by the use of a
primary, isotype-matched control antibody (Fig. 2D). Consequently, the mRNA levels of
CXCL1, CLCX8, CXCL9, CXCL10, and CXCL11 were shown to be elevated following
S. aureus invasion (Fig. 2E). The presence of intracellular S. aureus in osteocytes and the
above-described host cell response were also conﬁrmed in bone retrieved from PJI
patients. Acetabular bone specimens from two patient cohorts, 24 with PJI (15 males
and 9 females; age range, from 39 to 89 years) and 13 control patients with femoral
neck fracture and no evidence of infection (3 males and 10 females; age range, from 22
to 87 years) were collected for examination. All members of the PJI cohort were
S. aureus culture positive, as determined by routine diagnostic analysis of surgical
biopsy specimens, and all were undergoing treatment by staged-revision total hip
replacement surgery. A specimen from the iliac wing was also obtained from each
patient to be able to compare the biopsy specimens with a skeletal site that was distal
from the infected region and displayed no clinical signs of infection. All biopsy
procedures were approved by the Human Research Ethics Committees of the Royal
Adelaide Hospital and the University of Adelaide. Immunostaining (Fig. 2F), as well as
intense staining of individual osteocyte lacunae and apparently viable osteocytes
(Fig. 2F=), was carried out to examine specimens for the presence of S. aureus within
bone tissue, and it identiﬁed S. aureus within the bone marrow. A three-dimensional
reconstruction video of in situ confocal microscopy, scanning to a depth of 9 m, was
generated to conﬁrm intracellular, cytoplasmic immunostaining of S. aureus (Movie S3).
The speciﬁcity of staining was validated using isotype-matched antibody (Fig. 2G and
G=). No positive staining was detected either in the corresponding iliac wing sample
from the same patient or in acetabular samples from the femoral fracture cohort
(Fig. S3A and S3B). Consistent with the presence of S. aureus in the PJI cohort bone,
mRNA levels of a number of chemokines stimulated by infection, including CCL5, CXCL9,
CXCL10, and CXCL11 (Fig. 2H), were upregulated in bone specimens from the infected
acetabulum site of PJI patients but not the uninfected iliac wing. Signiﬁcantly elevated
levels of these mRNA species were not observed in specimens from either acetabulum
or iliac sites from the fracture cohort.
In summary, we have conﬁrmed that S. aureus is capable of infecting human
FIG 1 Legend (Continued)
indicated. ND, nondetectable. (K) Production of the chemokines RANTES, IL-8, and IP10 by osteocyte-like
cells after 24 h of exposure to S. aureus WCH-SK2 at MOIs of 0, 1, 10, and 100 (mean levels  SEM from 3
independent biological replicates); the effect of each MOI on chemokine production was tested by one-way
ANOVA, with relevant P values indicated.
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osteocytes both in in vitro cell cultures and in ex vivo-infected bone tissue. We also
demonstrate the presence of S. aureus antigens in viable osteocytes present in regions
of infected PJI patient bone. Our ﬁndings extend previous observations that undiffer-
entiated osteoblasts can become infected by S. aureus (7) and that S. aureus can invade
the lacuno-canalicular spaces of mouse cortical bone in an experimental infection
model (13). Our in vitro and clinical ﬁndings demonstrate that osteocytes are capable
of responding robustly to S. aureus invasion by producing immune mediators, consis-
tent with previous ﬁndings with other nonprofessional antigen-presenting cell types,
including osteoblasts (23). Some of the upregulated chemokines in this study, such as
RANTES (24) and IP10 (25), were previously shown to have direct antimicrobial activity
to clear extracellular bacteria. In our osteocyte-like cell model, whether the reduced live
FIG 2 Interaction between osteocytes and S. aureus ex vivo and in clinical PJI specimens. (A and B)
Presence of S. aureus (white arrowheads) in osteocyte (Ot)-occupied lacunae in bone tissue after ex vivo
infection; (C) presence of S. aureus (white arrowhead) in empty lacunae (EL); (D) isotype-matched control
immunostaining of infected bone tissue; (E) upregulation of mRNA levels of CXCL1, CXCL8, CXCL9, CXCL10,
and CXCL11 in infected bone samples in comparison to control samples (the y axis represents log2 values
of mRNA fold change [FC] and mean normalized expression  SEM from 3 independent biological
replicates); (F) immunostaining targeting S. aureus (red ﬂuorescence) in the acetabular bone of a PJI
patient, with the box marked by a broken red line indicating the enlarged area in panel F=; (F=)
high-magniﬁcation image of S. aureus staining of osteocytes/osteocyte lacunae (white arrowheads); (G)
isotype-matched control immunostaining of PJI patient acetabular bone; (G=) high-magniﬁcation image
of control staining of osteocytes/osteocyte lacunae; (H) boxplots (median with interquartile range)
showing relative mRNA levels (normalized to that of the glyceraldehyde-3-phosphate dehydrogenase
[GAPDH] gene) of CCL5 (P  0.026), CXCL9 (P  0.038), CXCL10 (P  0.054), and CXCL11 (P  0.0070) in
bone specimens from the iliac wing and acetabulum of the PJI cohort (n  23) and femoral fracture
cohort (n  13). P values indicate the comparisons between acetabulum bone and iliac wing bone from
PJI patients. BM, bone marrow.
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intracellular S. aureus cell number is associated with chemokine production, production
of another mediator, or lysosomal digestion by the host cell or a combination of all
three is an important question that needs to be addressed. This might potentially give
rise to a novel therapeutic approach, stimulating osteocytes to clear the viable intra-
cellular bacteria that are refractory to the effects of antibiotics. The bony location of the
infected osteocyte may render them refractory to clearance by immune cells, and, as
such, osteocytes may be an immune-privileged cell type. The osteocyte may therefore
serve as a reservoir of bacteria for future reinfection, perhaps explaining the high
prevalence of infections that become apparent only after long periods of time or recur
following surgical/medical management.
Our ﬁndings also demonstrate the capacity for planktonic-phase S. aureus to rapidly
switch to an SCV lifestyle upon interaction with osteocytes, indicative of an adaptation
to stress from the host cell. A previous study identiﬁed the presence of S. aureus SCVs
in ﬁbroblasts in tissue from chronic PJI patients and suggested that infections with SCVs
represented a problematic subset of cases (26). Our ﬁndings suggest that SCVs form
upon interaction with osteocytes, and, as such, all S. aureus PJIs have the potential to
become chronic if this occurs. SCVs have been demonstrated to be signiﬁcantly less
sensitive to most antibiotic treatments, and this mechanism of dormancy has been
suggested to be a strategy for bacteria to survive, either in bioﬁlm or inside host cells
in chronic diseases (27). Other cell types, such as ﬁbroblasts (26) and osteoclasts (8),
have been proposed as reservoirs for S. aureus infection in PJIs; however, these are
relatively short-lived cells. Osteoblast infection has also been proposed, and while the
nature of this cell type is transient, the cell type is capable of differentiating into
osteocytes, and infected osteoblasts have been shown to retain the ability to differen-
tiate in vitro (7). Given that differentiated osteocytes are the most numerous and
long-lived cell type encountered by bacteria in hard-bone tissue and demonstrate
viability upon infection with intracellular S. aureus, osteocytes might be the ideal host
cell type for S. aureus to survive in the long term. We propose that further investigation
of the role of the osteocyte in PJI is warranted.
Human-osteocyte-like cell model. Isolation and maintenance of primary human
osteoblasts were performed as previously established (18). Cells were then differen-
tiated in alpha minimal essential medium (MEM; Life Technologies, Inc., Grand Island,
NY, USA) containing 5%, vol/vol, fetal calf serum (FCS; Thermo-Fisher Scientiﬁc,
Scoresby, VIC, Australia), 1.8 mM potassium dihydrogen phosphate (Sigma-Aldrich, St.
Louis, MO, USA), 100 M ascorbate-2-phosphate (Sigma-Aldrich), and standard tissue
culture L-glutamine–antibiotics (Life Technologies, Inc.). Cells were allowed to differen-
tiate for 4 weeks in a humidiﬁed incubator in an atmosphere of 5% CO2–normoxia at
37°C.
Bacterial strains. The clinical isolate of S. aureus used, unless otherwise stated, was
WCH-SK2 (17). S. aureus stain RN6390 engineered with green ﬂuorescent protein (GFP) (20)
was kindly provided by Clare Cooksley (Basil Hetzel Institute, SA, Australia). All bacterial-
suspension cultures were maintained in Terriﬁc broth (ThermoFisher Scientiﬁc, Carlsbad,
CA, USA) at 37°C with agitation, and bacterial colonies were grown on Terriﬁc broth with
1.2%, wt/vol, agar.
Human bone biopsy specimens. Bone specimens from two cohorts, namely,
patients identiﬁed with S. aureus-related PJI following total hip replacement or a
femoral fracture, were collected for immunohistochemistry and gene expression anal-
yses. Samples from two different skeletal sites, the acetabulum and iliac wing, were
included. Bone samples from femoral fracture patients were also utilized for ex vivo
infection experiments. All the usage and operation procedures for collecting human bone
biopsy specimens were approved by the Human Research Ethics Committees of the Royal
Adelaide Hospital and the University of Adelaide.
In vitro and ex vivo infection of osteocytes and bacterial colony recovery.
S. aureus WCH-SK2 actively growing in its log-phase stage was used for in vitro and ex
vivo infection experiments, except for the live-cell imaging observation. A colorimetric
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method measuring light absorption of a bacterial suspension at 600 nm was employed
to determine the number of CFU per volume for standardizing a multiplicity of infection
(MOI). Bacterial suspensions were adjusted in phosphate-buffered saline (PBS) to
achieve an MOI of 1, 10, or 100 for the purposes of testing the dosage-dependent
effects of MOIs on the production of chemokine levels; otherwise, an MOI of 100 was
used. Bacterial suspensions were then used to inoculate differentiated osteocyte-like
cultures. After an initial infection period of 2 h, media were aspirated and replaced
with antibiotic-free differentiation medium supplemented with 20 g/ml lysostaphin
(Sigma-Aldrich) to lyse remaining extracellular bacteria. An estimation of total host cell
number 30 days postinfection in both control and infected cultures was carried out by
counting the eukaryotic nuclei number using DAPI (4=,6-diamidino-2-phenylindole)
staining and ﬂuorescence microscopy (Olympus IX71 microscope) and by image anal-
ysis using ImageJ software (NIH, Bethesda, MD, USA). Osteocyte-like cultures were lysed
in TRIzol reagent 24 h postinfection before performance of gene expression analyses as
described below, and cell culture supernatants were collected for measuring secreted
protein levels of RANTES (enzyme-linked immunosorbent assay [ELISA] kit; Caribbean Park,
VIC, Australia), IL-8 (ELISA kit), and IP10 (DIP100; R&D Systems, Minneapolis, MN, USA) by
ELISA. For ex vivo infection experiments, bone specimens from femoral fracture patients
were dissected into 1-mm3 pieces and washed with PBS to remove the bone marrow
fraction. Cleaned bone pieces were then cultured without bacteria as a control and with
S. aureus adjusted to 103 CFU per mm3 of bone volume as the infected group for 12 h.
Specimens from both groups were then processed both for total RNA extraction using the
TRIzol method and for immunostaining to detect S. aureus.
For the recovery of intracellular bacteria, osteocyte-like cultures were lysed in sterile
water. Cell lysates were evenly distributed on Terriﬁc broth/agar plates and cultured
overnight at 37°C in 5% CO2. Agar plates were then kept at room temperature under
aerobic conditions for 48 h to develop a gold pigmentation in resultant colonies, which
is a typical feature of planktonic S. aureus. Following such growth development, colonies
with a 0.2-mm diameter or less were counted as SCVs; both total colony counts and
percentages of cells that were SCVs were recorded from each of the retrieval time points.
Live-cell imaging of osteocyte-like cell infection. For live-cell imaging, primary
human osteoblasts were seeded in 8-well chamber slides (ibidi GmbH, Martinsried,
Germany) and differentiated for 4 weeks, as described above. GFP-expressing S. aureus
RN6390 was used to inoculate osteocyte-like cultures at an MOI of 10 for 2 h, followed
by removal of extracellular bacteria by lysostaphin digestion. A Nikon TiE microscope
with live-cell culturing components was utilized for imaging the interaction between
host cells and bacteria over a 24-h time course. Osteocyte-like cells were visualized
using the differential interference contrast (DIC) channel, and S. aureus cells were
visualized using the GFP channel (excitation at 475 nm, emission collection between
520 and 560 nm). Images of identical regions within control and infected groups were
taken every 5 min, and all serial images were stitched to generate video ﬁles for each
treatment group. The video ﬁles in Movie S1 and S2 demonstrated the cell activities
from 4 to 24 h. The movements of one infected cell from 13 to 18 h are depicted in
Fig. 1B. Osteocyte-like cell plasma membrane movement was quantiﬁed from serial
static images with a 30-min interval, using ImageJ software.
TEM visualization of intracellular S. aureus. Osteocyte-like cultures were infected
with S. aureusWCH-SK2 in T75 ﬂasks. Cells were harvested in pellet form 24 h postinfection
and sequentially stabilized in ﬁxative comprising 4%, wt/vol, paraformaldehyde–1.25%,
wt/vol, glycolaldehyde in PBS (pH 7.2) and then in 2%, wt/vol, osmium tetroxide in water.
Cell pellets were embedded in resin blocks, and 5-m sections were taken for trans-
mission electron microscopy (TEM; Philips CM200) imaging.
Preparation of total RNA and reverse transcription (RT)-PCR analysis. Total RNA
samples were prepared from ex vivo bone tissue, in vitro osteocyte-like cultures, and
bacterial colonies by using TRIzol reagent (Life Technologies, Inc.) as per the manufac-
turer’s instructions. For RNA isolation from bacteria, 30 min of lysostaphin (20 g/ml)
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digestion at 37°C was performed prior to the addition of TRIzol (28). cDNA was
synthesized using the iScript kit (Bio-Rad Laboratories, Hercules, USA). The mRNA
expression of genes of interest was measured by real-time PCR using the RT2 SYBR
Green quantitative PCR (qPCR) master mix (Qiagen, Limburg, the Netherlands), and
relative expression was analyzed using the ΔCT method (where CT is threshold cycle).
The efﬁciency of all primer pairs used (Table S1) was close to optimal, since a 10-fold
dilution of the template resulted in an increase in CT by 3.3-fold (data not shown).
Gene microarray and bioinformatics analysis. For each sample, 400 ng total RNA
was ampliﬁed using the Ambion whole-transcript (WT) expression kit (ThermoFisher),
and the Affymetrix GeneChip WT terminus-labeling kit (ThermoFisher) was employed to
produce biotin-labeled fragmented cDNA. Each labeled cDNA sample was hybridized to
the Affymetrix human gene 2.0 ST array for 17 h at 45°C. Experimental triplicates of
gene chip hybridization were carried out for both the control and infected groups.
Microarray chips were washed and stained with a ﬂuorescence-labeled antibody using
a model 450 Affymetrix ﬂuidics station. Gene chips were scanned using an Affymetrix
3000 7G scanner. Microarray analysis was performed using Partek Genomics Suite v6.5.
The generated raw data as .Cel ﬁles were processed using the multiarray average (RMA)
method (29). Comparisons between treatments were performed by analysis of variance
(ANOVA), with Benjamini-Hochberg false-discovery rate (FDR) correction for multiple
tests (30). Genes were considered signiﬁcantly differentially expressed (DE) using an
FDR-adjusted P value of 0.01 and an estimated log2 fold change (log2FC) beyond 1,
giving 1,526 unique Entrez Gene identiﬁers considered to be DE. The set of DE
identiﬁers was tested for enrichment of Gene Ontology (GO) terms using the Fisher
exact test and a set of background genes, deﬁned as those included on the array but
with an unadjusted P value of 0.05. GO terms with fewer than 4 steps back to the
ontology roots were discarded, leaving 8,607 GO terms tested for enrichment. GO terms
were considered enriched in the set of DE genes if they received a Bonferroni-adjusted
P value of0.05, yielding 202 enriched GO terms. For the purposes of visualization, GO
terms were formed into communities using the common genes within each term (31),
with the “hub” or most-connected GO terms labeled in Fig. S1B.
Immunohistochemistry analyses on human bone biopsy specimens. Bone spec-
imens for immunohistochemistry analysis were stabilized and decalciﬁed in TheraLin
tissue ﬁxative (Grace Bio-Labs, Bend, OR, USA) at room temperature for 3 days. Samples
were then embedded in parafﬁn, and 10-m sections from each of the samples were
taken to perform immunohistochemistry staining. Antibody targeting S. aureus
(AB37644; Abcam, Inc., Cambridge, MA, USA) was used at a 1:100 dilution for staining
at 4°C for 1 h to detect the pathogen. Primary antibody signals were tagged by Alexa
Fluor 647-conjugated rabbit anti-mouse IgG (HL) secondary antibody (A-21239; Life
Technologies, Inc.) for visualization. The speciﬁcity of antibody staining was validated
by following the same staining procedures, using matched-isotype control antibody
(14-4742-81; ThermoFisher) for primary detection. DAPI was employed to label
nuclei of cells through all sections. All samples were imaged with an Olympus
FV3000 confocal microscope. The underlying bone structure was visualized using
the transmission detection function, which generates a gray-scale image of the
tissue section surface.
Statistical analyses. One-tailed t tests with Welch’s correction were used for
examining the differences in cell movements in Fig. 1B, mRNA levels of the chemokine
gene panel in Fig. 1J, and gene expression in bone biopsy specimens between infection
and iliac wing sites from the PJI cohort in Fig. 2H. One-tailed tests were used in the case
of membrane movement because cells clearly changed from an inactive to an active
state and in the case of host cell gene expression responses, because gene microarray
analysis indicated that the genes examined were strongly induced. Two-tailed t tests
with Welch’s correction were employed for examining the differences in total cell
numbers in Fig. 1A and sigB mRNA levels in Fig. 1I, because no assumption was made
for the behavior of either host cells or bacteria. One-way ANOVA tests were used for
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determining the effects of various MOIs on chemokine production levels in Fig. 1K.
Exact P values for each test are shown on the respective ﬁgure, where applicable.
Statistical analysis was not applicable for data sets containing nondetectable (ND)
values.
Accession number(s). Microarray experiment raw ﬁles have been deposited in the
server of ArrayExpress (https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6700/)
and made available to the public.
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